Fig. 4: Results of NMAs for OS of patients with BCR.

A RT-based treatment: A1 Forest plots, A2 Treatment ranking based on SUCRA graph, B Hormone-based treatment: B1 Forest plots, B2 Treatment ranking based on SUCRA graph. PRISMA preferred reporting items for systematic reviews and meta-analyses, MFS metastatic-free survival, HT hormone therapy, RT radiation therapy, OS overall survival, DOC docetaxel, ADT androgen deprivation therapy, NMA network meta-analysis, BCR biochemical recurrence, SUCRA surface under the cumulative ranking.